SWAP-MEAT: Study With Appetizing Plant Food - Meat Eating Alternatives Trial
NCT03718988 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2023-02-21
Summary
This study aims to investigate the impact of replacing meat consumption with plant-based meat alternative consumption on cardiovascular health, the gut microbiome, and metabolic status.
Conditions
- Microbiome
- Immune Function
- Cardiovascular Diseases
Interventions
- BEHAVIORAL
-
Meat products
Traditional meat products (beef burger patties, pork sausage, etc.)
- BEHAVIORAL
-
Plant Alternative products
Plant-based alternatives (The Beyond Burger, Beyond Sausage, etc.)
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Christopher D. Gardner, PhD · Stanford University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-01-17
- Primary Completion
- 2019-12-05
- Completion
- 2019-12-05
Countries
- United States
Study Locations
More Related Trials
-
Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
NCT04990544 ·Status: UNKNOWN ·Phase: PHASE2
-
A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19
NCT05682638 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults
NCT01160172 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)
NCT00534248 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals
NCT05472038 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Trial of Recombinant Hepatitis E Vaccine
NCT01014845 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years
NCT04895982 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age
NCT03170609 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults
NCT07095231 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection
NCT05364242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults
NCT01537185 ·Status: COMPLETED ·Phase: PHASE1
-
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19
NCT04672395 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2
NCT04611802 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19
NCT04844268 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults
NCT04758962 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers
NCT01375933 ·Status: COMPLETED ·Phase: PHASE3
-
Anthrax Vaccine Clinical Trials
NCT00114621 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines
NCT05933512 ·Status: UNKNOWN ·Phase: PHASE2
-
GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)
NCT04673149 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study
NCT02937233 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects
NCT04563702 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults
NCT04816669 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19
NCT04646590 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
NCT04516746 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine
NCT05040789 ·Status: WITHDRAWN ·Phase: PHASE3